Absence of transaminase increase after 4-week administration of fondaparinux (Arixtra®), a new synthetic and selective inhibitor of factor Xa, in the PENTHIFRA-Plus study - Lassen,M.; Bauer,K.A.; Eriksson,B.I.; Turpie,A.GG. (J Thromb Haemost, 2003)